StonvexLoading…
StonvexStonvexStonvexCore line items from OLLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $2.65B | $2.27B | $2.10B | $1.83B |
Operating Income | $297.67M | $249.50M | $227.80M | $130.92M |
Net Income | $240.60M | $199.76M | $181.44M | $102.79M |
EPS (Diluted) | $3.89 | $3.23 | $2.92 | $1.64 |
Total Assets | $2.95B | $2.56B | $2.29B | $2.04B |
Total Liabilities | $1.07B | $865.84M | $786.36M | $682.03M |
Cash & Equivalents | $259.68M | $205.12M | $266.26M | $210.60M |
Free Cash Flow OCF − CapEx | $194.66M | $106.90M | $130.09M | $62.68M |
Shares Outstanding | 61.77M | 61.77M | 62.07M | 62.70M |